Filing Details
- Accession Number:
- 0000014272-17-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-07 16:39:33
- Reporting Period:
- 2017-03-03
- Filing Date:
- 2017-03-07
- Accepted Time:
- 2017-03-07 16:39:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199294 | Sandra Leung | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2017-03-03 | 116,100 | $27.01 | 488,063 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2017-03-06 | 92,405 | $57.02 | 395,658 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2017-03-03 | 116,100 | $0.00 | 116,100 | $27.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 5,847 | Indirect | By BMY Savings and Investment Program |
Footnotes
- A portion of the proceeds from the sale of these shares were used to cover the exercise price and taxes of the Option exercised on March 3, 2017. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $56.64 to $57.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- All of the shares are currently exercisable.
Billionaire Hedge Funds
